ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Sjogren’s syndrome"

  • Abstract Number: 2876 • 2017 ACR/ARHP Annual Meeting

    Analysis of Autoantibody Reactivity to the Complete Human Peptidome By Phage Immunoprecipitation Sequencing Does Not Identify a Predominant Novel Autoantibody in Sjogren’s Syndrome

    Tiezheng Yuan1, Michelle Petri2, Alan N. Baer3 and H. Benjamin Larman1, 1Pathology (Immunology), Johns Hopkins University School of Medicine, Baltimore, MD, 2Medicine (Rheumatology), Division of Rheumatology, Johns Hopkins University School of Medicine, MD, USA, Baltimore, MD, 3Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: An unbiased and comprehensive approach to the analysis of Sjögren’s syndrome (SS) antibody repertoires would provide important data on its pathogenesis. Phage ImmunoPrecipitation sequencing…
  • Abstract Number: 555 • 2017 ACR/ARHP Annual Meeting

    The Corrected QT(QTc) Interval Is Associated with Myocardial Fibrosis in Primary  Sjögren Syndrome, Assessed By a Cardiac Magnetic Resonance Approach: A Prospective Pilot Study at a Single Center

    Atsuma Nishiwaki1, Hitomi Kobayashi1, Isamu Yokoe2, Yosuke Nagasawa3, Kaita Sugiyama3, Natsumi Ikumi4, Takamasa Nozaki3, Noboru Kitamura5 and Masami Takei5, 1Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 2Rheumatology, Kyoundo Hospital, Sasaki Institute, Tokyo, Japan, 3Nihon University School of Medicine, Tokyo, Japan, 4St. Vincent's University Hospital, Department of Rheumatology, Dublin, Ireland, 5Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan

    Background/Purpose: Congenital heart block in the fetus and neonate, which can cause acquired QT prolongation, may be associated with maternal anti-SS-A/anti-SS-B autoantibodies. However, there are…
  • Abstract Number: 876 • 2017 ACR/ARHP Annual Meeting

    Epidemiologic Subsets Drive a Differentiated Clinical and Immunological Presentation of Primary Sjögren Syndrome: Analysis of 9302 Patients from the Big Data International Sjögren Cohort

    Soledad Retamozo1,2,3, Pilar Brito-Zerón3,4, Margit Zeher5, Kathy L. Sivils6, Raphaele Seror7, Thomas Mandl8, Xiaomei Li9, Chiara Baldini10, Jacques-Eric Gottenberg11, Debashish Danda12, Roberta Priori13, Luca Quartuccio14, Gabriela Hernandez-Molina15, Aike A. Kruize16, Seung-Ki Kwok17, Marie Wahren-Herlenius18, Sonja Praprotnik19, Damien Sene20, Roberto Gerli21, Roser Solans22, Yasunori Suzuki23, David A. Isenberg24, Maureen Rischmueller25, Gunnel Nordmark26, Guadalupe Fraile27, Piotr Wiland28, Hendrika Bootsma29, Takashi Nakamura30, Valeria Valim31, Roberto Giacomelli32, Valérie Devauchelle-Pensec33, Benedikt Hofauer34, Michele Bombardieri35, Virginia Fernandes Moça Trevisani36, Daniel S. Hammenfors37, Steven E. Carsons38, Sandra Gofinet Pasoto39, Jacques Morel40, Tamer Gheita41, Fabiola Atzeni42, Cristina F. Vollenweider43, Belchin Kostov44, Xavier Mariette45 and Manuel Ramos-Casals46, 1Rheumatology Unit, Hospital Privado Universitario de Córdoba, Institute University of Biomedical Sciences University of Córdoba (IUCBC), Cordoba, Argentina, 2Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Córdoba, Consejo Nacional de Investigaciones Científicas y Técnicas (INICSA-UNC-CONICET), Cordoba, Argentina, 3Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Barcelona, Spain, 4Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona., Bacelona, Spain, 5Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Debrecen, Hungary, 6Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 7Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France, Paris, France, 8Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, Lund, Sweden, 9Department of Rheumatology and Immunology, Anhui Medical University Affiliated Provincial Hospital, China, Hefei, Anhui, China, 10Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, 11Department of Rheumatology, Strasbourg University Hospital, Université de Strasbourg, CNRS, Strasbourg, France, Strasbourg, France, 12Clinical Immunology & Rheumatology, Christian Medical College, Vellore, India, Vellore, India, 13UO Complessa Reumatologia, Policlinico Umberto I Università Sapienza di Roma, Rome, Italy, 14Rheumatology Clinic, DSMB, University of Udine, Udine, Italy, Udine, Italy, 15Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición SZ, mexico city, Mexico, 16Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 17[email protected], Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), 18Unit of Experimental Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 19Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 20Service de Médecine Interne 2, Hôpital Lariboisière, Université Paris VII, Assistance Publique-Hôpitaux de Paris, 2, Paris, France, Paris, France, 21University and Azienda Ospedaliera of Perugia, Perugia, Italy, 22Autoimmune Systemic Diseases Unit, Department of Internal Medicine, Hospital Vall d'Hebron, Autonomous University of Barcelona, Spain, Barcelona, Spain, 23Division of Rheumatology, Kanazawa University Graduate School of Medicine, Ishikawa, Japan, Kanazawa, Japan, 24Centre for Rheumatology Research, Division of Medicine, University College London, London, United Kingdom, 25Rheumatology, The Queen Elizabeth Hospital, South Australia, Adelaide, Australia, 26Department of Medical Sciences, Section of Rheumatology, Uppsala University, Uppsala, Sweden, Uppsala, Sweden, 27Autoimmune Diseases Department, Hospital Ramón y Cajal, Madrid, Spain, 28Department and Clinic of Rheumatology and Internal Medicine, Medical University, Wroclaw, Poland, 29Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 30Department of Radiology and Cancer Biology, Nagasaki University School of Dentistry, Nagasaki, Japan, 31Rheumatology, Department of Medicine, Universidade Federal do Espírito Santo, Vitória, Brazil, Vitória, Brazil, 32University of L'Aquila, L'Aquila, Italy, 33Department of Rheumatology, Brest University Hospital, Brest, France, 34Hals-Nasen-Ohrenklinik und Poliklinik, Technische Universität München, München, Germany, München, Germany, 35Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, UK, London, United Kingdom, 36UNIFESP, Sao Paulo, Brazil, San Paulo, Brazil, 37Department of Rheumatology, Haukeland University Hospital, University of Bergen, Bergen, Norway, 38NYU Winthrop University Hospital, Department of Medicine, Mineola, NY, 39Internal Medicine, Division of Rheumatology - Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, São Paulo, Brazil, 40Department of Rheumatology, Teaching hospital and University of Montpellier, France, Montpellier, France, 41Rheumatology, Rheumatology Department, Faculty of Medicine, Cairo University, Egypt, Cairo, Egypt, 42Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy, 43Rheumatology, German Hospital, Buenos Aires, Argentina, Buenos Aires, Argentina, 44Primary Care Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Primary Care Centre Les Corts, CAPSBE, Barcelona, Spain, 45Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, Paris, France, 46Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Spain, Barcelona, Spain

    Background/Purpose: To analyse whether epidemiologic factors (such as gender or age at diagnosis of the disease) are associated with particular disease expressions and define some…
  • Abstract Number: 1496 • 2017 ACR/ARHP Annual Meeting

    The Performance of Different Classification Criteria in Patients with Primary Sjogren’s Syndrome and Analysis of Their Contribution for Definitive Diagnosis, When Either Criteria Used Alone or in Combination

    Zehra Kosuva Ozturk1, Gokce Kenar2, Handan Yarkan3, Berrin Zengin2, Gercek Can2, Fatos Onen2 and Merih Birlik4, 1internal medicine, dokuz eylul universty, izmir, Turkey, 2Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, 3Rheumatology, Dokuz Eylul University Faculty of Medicine, İzmir, Turkey, 4Rheumatology, Dokuz Eylul University Faculty of Medicine, izmir, Turkey

    Background/Purpose: Many classification criteria sets have for primary Sjšgren's Syndrome (pSS).We aimed to compare the performance of 3 classification criteria sets for pSS, to determine…
  • Abstract Number: 2877 • 2017 ACR/ARHP Annual Meeting

    Premature Senescence of Naive CD4+ T-Cells in Primary Sjogren’s Syndrome

    Patrizia Fasching1, Johannes Fessler2, Andrea Raicht3, Angelika Lackner2, Josef Hermann2, Rusmir Husic1, Sabrina Hammerl4, Winfried Graninger2, Wolfgang Schwinger3, Christian Dejaco1 and Martin Stradner1, 1Department of Rheumatology and Immunology, Medical University of Graz, Graz, Austria, 2Rheumatology and Immunology, Medical University of Graz, Graz, Austria, 3Division of Pediatric Hemato-Oncology, Medical University of Graz, Graz, Austria, 4Medical University of Graz, Graz, Austria

    Background/Purpose: Lymphopenia is a frequent finding in primary Sjögren’s syndrome (pSS) affecting mostly the CD4+ T-cell population. Here we examine possible underlying defects in thymic…
  • Abstract Number: 556 • 2017 ACR/ARHP Annual Meeting

    Identification and Validation of S100 Salivary Proteins As Putative Biomarkers for Different  Subsets of Primary Sjögren’s Syndrome Patients

    Chiara Baldini1, Francesco Ferro2, Nadia Ucciferri3, Enza Polizzi2, Silvia Rocchiccioli3, Marta Mosca2 and Antonella Cecchettini3, 1Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, 2Rheumatology Unit, University of Pisa, Pisa, Italy, 3IFC, CNR, Pisa, Italy

    Background/Purpose: S100 A proteins are multifunctional proteins expressed predominantly by myeloid cells, with a regulatory role in a variety of cellular processes including inflammation. Recently,…
  • Abstract Number: 877 • 2017 ACR/ARHP Annual Meeting

    Modification of the  Classification Criteria for Primary Sjögren Syndrome: An International Vignette Survey

    Sandrine Jousse-Joulin1, Florence Gatineau2, Chiara Baldini3, Alan N. Baer4, Francesca Barone5, Hendrika Bootsma6, Simon Bowman7, Pilar Brito Zeron8, Divi Cornec9, Thomas Doerner10, Salvatore De Vita11, Benjamin Fisher12, Daniel S. Hammenfors13, Malin V. Jonsson14, Xavier Mariette15, Vera Milic16, Hideki Nakamura17, Wan-Fai Ng18, Emmanuel Nowak2, Manuel Ralos-Casals19, Astrid Rasmussen20, Raphaèle Seror21, Caroline Shiboski22, Takashi Nakamura23, Arjan Vissink24, Alain Saraux25 and Valérie Devauchelle-Pensec1, 1Rheumatology, Brest university medical school, EA 2216, UBO and CHU de la Cavale Blanche,, Brest, France, 2INSERM CIC 1412, Brest Medical University Hospital, Brest, France, 3Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, 4Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, 5Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham, United Kingdom, 6Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands, 7Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, Birmingham, United Kingdom, 8Autoimmune Diseases Unit, Department of Internal Medicine, Hospital CIMA-Sanitas, Barcelona, Spain, 9CHU Brest, Brest, France, 10Charité Universitätmedizin Berlin and DRFZ, Berlin, Germany, 11Rheumatology Clinic, Academic Hospital S. M. della Misericordia, Medical Area Department, University of Udine, Italy, Udine, Italy, 12Rheumatology Research Group, University of Birmingham, Birmingham, United Kingdom, 13Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, Bergen, Norway, 14Section for Oral and Maxillofacial Radiology, Department of Clinical Dentistry, University of Bergen, Bergen, Norway, Bergen, Norway, 15Université Paris Sud, Paris, France, 16Institute of Rheumatology, School of Medicine, University of Belgrade, Belgrade, Serbia, 17Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 18Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 19Department of Medicine, University of Barcelona, Barcelone, Spain, 20Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 21Assistance Publique-Hôpitaux de Paris (APHP), Hôpitaux universitaires Paris Sud, Université Paris Sud, kremlin bicetre, France, 22Department of Orofacial Sciences, School of Dentistry, University of California, San Francisco, CA, 23Department of Radiology and Cancer Biology, Nagasaki University School of Dentistry, Nagasaki, Japan, 24Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 25Rheumatology Department, Rheumatology Department, CHU de la Cavale Blanche, Brest, France, Brest Cedex, France

    Background/Purpose: The common classification criteria sets of primary Sjogren syndrome, did not considered the ultrasonography (US) of the major salivary glands as a useful item.…
  • Abstract Number: 1498 • 2017 ACR/ARHP Annual Meeting

    Long-Term Cohort of Patients with a Clinical Diagnosis of Sjogren’s Syndrome: Activity Index and Patient Reported Outcome Performance

    Anna Viola Taulaigo1, Maria Francisca Moraes-Fontes1, Melissa Fernandes2, Vera Bernardino2 and Tiago Ramires3, 1Unidade de Doenças Auto-imunes, Hospital Curry Cabral, Centro Hospitalar de Lisboa Central, Lisbon, Portugal, 2Unidade de Doenças Auto-imunes, Hospital Curry Cabral, Centro Hospitalar de Lisboa Central, Lisboa, Portugal, 3Unidade de Doenças Auto-imunes, Hospital Curry Cabral, Centro Hospitalar de Lisboa Central, Lisbon, Portugal; Serviço de Medicina Interna, Hospital Espírito Santo, Évora, Portugal, Lisbon, Portugal

    Background/Purpose: There have been three classification proposals for Sjögren´s Syndrome (SS) over the past 15 years (1-3). The 2016 criteria require a diagnostic work-up which…
  • Abstract Number: 557 • 2017 ACR/ARHP Annual Meeting

    Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Peripheral Blood Mononuclear Cells in Sjögren’s Syndrome

    Seong-Kyu Kim1, Jung-Yoon Choe2, Sung-Hoon Park3 and Hwajeong Lee2, 1Rheumatology, Catholic University of Daegu School of Medicine, Daegu, Korea, Republic of (South), 2Catholic University of Daegu School of Medicine, Daegu, Korea, Republic of (South), 3Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea, Republic of (South)

    Background/Purpose: Sjögren's syndrome is a systemic autoimmune disease characterized by lymphocyte infiltration and subsequent dysfunction of exocrine glands, finally leading to dryness in the exocrine…
  • Abstract Number: 878 • 2017 ACR/ARHP Annual Meeting

    Diagnosis of Salivary Gland Lymphoma in Sjogren’s Syndrome Utilizing Ultrasound-Guided Core Needle Biopsies

    Alan N. Baer1, Thomas Grader-Beck1, Brendan Antiochos1, Julius Birnbaum1, Qing Kay Li2, Deborah Belchis2 and Joel Fradin3, 1Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, 2Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Radiology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Ultrasound (US)-guided core needle biopsy (CNB) with or without concomitant fine needle aspiration (FNA) is a standard method for pre-operative evaluation of salivary gland…
  • Abstract Number: 1499 • 2017 ACR/ARHP Annual Meeting

    Major Salivary Gland Ultrasonography Bed-Side and Still Image Scoring – a Pilot Comparison in Juvenile Sjögren’s Syndrome

    Daniel S. Hammenfors1, Valeria Valim2, Sandra Gofinet Pasoto3, Vibke Lilleby4, Juan Carlos Nieto5, Clovis Silva6, Rosa M R Pereira7, Blanca Bica8, Johan G. Brun9, Roland Jonsson9 and Malin V. Jonsson10, 1Department of Rheumatology, Haukeland University Hospital, University of Bergen, Bergen, Norway, 2Rheumatology, Department of Medicine, Universidade Federal do Espírito Santo, Vitória, Brazil, Vitória, Brazil, 3Internal Medicine, Division of Rheumatology - Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, São Paulo, Brazil, 4Department of Rheumatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, Oslo, Norway, 5Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 6Department of Pediatric Rheumatology, Federal University of São Paulo, São Paulo, Brazil, 7Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil, 8Istituto Giannina Gaslini - Pediatria II, Reumatologia - PRINTO, Genova, Italy, 9Department of Rheumatology, Haukeland University Hospital, Bergen, Bergen, Norway, 10Section for Oral and Maxillofacial Radiology, Department of Clinical Dentistry, University of Bergen, Bergen, Norway, Bergen, Norway

    Background/Purpose: Adding major salivary gland ultrasonography (SGUS) improves the diagnostics of primary Sjögren’s syndrome (pSS). Juvenile Sjögren’s syndrome (jSS) is a rare, poorly defined disease.…
  • Abstract Number: 560 • 2017 ACR/ARHP Annual Meeting

    Clinical Relevance of Serum Free Light Chain Level As Biomarker in Primary Sjögren′s Syndrome

    Gwenny M. Verstappen1, Johan Bijzet1, Jolien F. van Nimwegen1, Martha S. van Ginkel1, Arjan Vissink2, Hendrika Bootsma1 and Frans G.M. Kroese1, 1Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: During immunoglobulin synthesis in B-cells, kappa and lambda light chains are produced in excess compared to heavy chains, and the surplus of light chains…
  • Abstract Number: 1064 • 2017 ACR/ARHP Annual Meeting

    Characterization of Human Tolerogenic Dendritic Cells Generated with Protein Kinase C Inhibitor and Induction from Patients with Autoimmune Diseases

    Hitoshi Hasegawa1, Takuya Matsumoto1, Endy Adnan2, Jun Ishizaki1, Koichiro Suemori1 and Masaki Yasukawa1, 1Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan, 2Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan

    Background/Purpose: Tolerogenic dendritic cells (tDCs) are a promising therapeutic tool for specific induction of immunological tolerance. Human tDCs can be generated ex vivo using various…
  • Abstract Number: 1500 • 2017 ACR/ARHP Annual Meeting

    Longitudinal Analysis of Different Therapeutic Strategies in Patients with Primary Sjögren’s Syndrome

    Kristen Davies1, Kamran Mirza1, Jessica Tarn2, Marian Regan3, Saravanan Vadivelu4, Gavin Clunie5, Jacqueline Andrews6, Elizabeth Price7, Steve Young-Min8, Ian Giles9, Bhaskar Dasgupta10, Cathy Lawson11, Nagui Gendi12, Neil J. McHugh13, Michele Bombardieri14, Costantino Pitzalis14, Nurhan Sutcliffe14, Simon Bowman15, Dennis Lendrem16,17 and Wan-Fai Ng2,18, 1Institute of Cellular Medicine, Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom, 2Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom, 3Royal Derby Hospital, Derby, UK, Derby, United Kingdom, 4Queen Elizabeth Hospital, Gateshead, UK, Gateshead, United Kingdom, 5Ipswich Hospital NHS Trust, Ipswich, UK, Ipswich, United Kingdom, 6Leeds Teaching Hospitals NHS Trust, Leeds, UK, Leeds, United Kingdom, 7Great Western Hospital, Swindon, UK, Swindon, United Kingdom, 8Queen Alexander Hospital, Portsmouth, UK, Portsmouth, United Kingdom, 9Centre for Rheumatology, University College London, Centre for Rheumatology, University College London, UK, London, United Kingdom, 10Rheumatology, Southend University Hospital NHS Foundation Trust, Southend, UK, Westcliff-on-Sea, United Kingdom, 11Harrogate District Hospital, Harrogate, UK, Harrogate, United Kingdom, 12Basildon and Thurrock University Hospital, Basildon, UK, Basildon, United Kingdom, 13Royal National Hospital for Rheumatic Diseases, Bath, UK, Bath, United Kingdom, 14Barts Health NHS Trust & Barts and the London School of Medicine & Dentistry, London, UK, London, United Kingdom, 15Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, Birmingham, United Kingdom, 16Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-upon-Tyne, United Kingdom, 17Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK, Newcastle, United Kingdom, 18Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom

    Background/Purpose: Primary Sjögren’s syndrome (pSS) is a systemic autoimmune rheumatic disease characterised by sicca features and systemic manifestations such as pain and fatigue. The classic…
  • Abstract Number: 562 • 2017 ACR/ARHP Annual Meeting

    Anti-Muscarinic Receptor 3 Antibodies – a Cross Reactive Result of Ro60 Immunization

    Syed M.S. Quadri1, Biji T Kurien2, Kristi A. Koelsch3 and R. Hal Scofield4, 1Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Okalahoma City, OK, 4Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Sjogren’s syndrome (SS) is a chronic autoimmune inflammatory disease characterized by impaired function of salivary and lacrimal glands leading to dry mouth and dry…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 26
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology